Latest Bendamustine Stories
IMBRUVICA Combination Data in Chronic Lymphocytic Leukemia to be Featured in Official ASCO Press Program SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
CORAL SPRINGS, Florida, April 15, 2015 /PRNewswire/ -- For consumers wanting to use supplements to improve their nutrition and sport performance through pharmaceutical
SUNNYVALE, Calif., March 16, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Data from 13 accepted abstracts include: NORTH CHICAGO, Ill., Nov.
- IMBRUVICA Net Product Revenue Increased to $109.5 million for the Second Quarter of 2014 - SUNNYVALE, Calif., July 31, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
WHITE PLAINS, N.Y., July 23, 2014 /PRNewswire-USNewswire/ -- Today's U.S.
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
BOCA RATON, Fla., June 23, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc.
- Research in hematological malignancies features: ibrutinib (IMBRUVICA®), siltuximab (SYLVANT(TM)) and daratumumab; research in solid tumors features: abiraterone acetate (ZYTIGA®), ARN-509, trabectedin
First full quarter after launch of IMBRUVICA(TM) net product revenue of $56.2 million SUNNYVALE, Calif., May 2, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.